Biblio
Manufacturing mesenchymal stromal cells for the treatment of graft-versus-host disease: a survey amongst centers affiliated to the European Group of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2018.
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest. 2013.
Ruxolitinib for tocilizumab-refractory severe COVID-19 infection. Br J Haematol. 2020.
.